DVT (+) n = 38 | DVT (−) n = 251 | p-value | |
---|---|---|---|
Age (years) | 71 ± 12 | 68 ± 11 | 0.058 |
Male | 15 (39.5%) | 160 (63.7%) | 0.004 |
Hypertension | 30 (78.9%) | 178 (71.2%) | 0.321 |
Diabetes | 15 (39.5%) | 72 (28.8%) | 0.182 |
Hyperlipidemia | 23 (60.5%) | 172 (68.8%) | 0.310 |
Smoking | 14 (36.8%) | 116 (48.4%) | 0.270 |
Previous stroke | 6 (15.8%) | 39 (15.5%) | 0.968 |
Peripheral artery disease | 16 (42.1%) | 92 (36.7%) | 0.517 |
Active cancer | 4 (1.6%) | 1 (2.6%) | 0.647 |
Stroke mechanism | |||
Large artery atherosclerosis | 15 (39.5%) | 65 (28.0%) | 0.132 |
Small vessel disease | 8 (21.1%) | 87 (34.8%) | |
Cardioembolism | 6 (15.8%) | 31 (12.4%) | |
Other determined | 1 (2.6%) | 1 (0.4%) | |
Undetermined | 8 (21.1%) | 66 (26.4%) | |
BMI (kg/m2) | 23.9 ± 3.5 | 23.9 ± 2.6 | 0.927 |
mRS before index stroke | 0.1 ± 0.4 | 0.2 ± 0.7 | 0.220 |
Initial NIHSS | 7.4 ± 5.4 | 4.1 ± 3.3 | < 0.001 |
NIHSS arm | 1.3 ± 1.2 | 1.0 ± 1.0 | 0.160 |
NIHSS leg | 2.0 ± 1.1 | 0.8 ± 1.0 | < 0.001 |
Laboratory results | |||
AST (mg/dL) | 40 ± 4 | 41 ± 5 | 0.732 |
ALT (mg/dL) | 46 ± 15 | 45 ± 13 | 0.428 |
BUN (mg/dL) | 18 ± 10 | 17 ± 5 | 0.342 |
Creatinine (mg/dL) | 0.8 ± 0.2 | 0.8 ± 0.4 | 0.297 |
D-dimer (mg/dL) | 1.2 ± 2.4 | 0.8 ± 1.2 | 0.123 |
FDP (μg/mL) | 7.3 ± 13.4 | 5.8 ± 9.0 | 0.433 |
Thrombolysis | 2 (5.3%) | 12 (4.8%) | 0.897 |
Concomitant antithrombotics | |||
Single antiplatelet | 30 (78.9) | 194 (77.3) | 0.765 |
Dual antiplatelet | 4 (10.5) | 36 (14.3) | |
Anticoagulation | 4 (10.5) | 21 (8.4) |